| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 966 | 920 | ||
| Accounts receivable, net | 1,015 | 1,101 | ||
| Inventories | 1,591 | 1,550 | ||
| Prepaid expenses and other current assets | 162 | 269 | ||
| Total current assets | 3,734 | 3,840 | ||
| Non-current inventories | 239 | 266 | ||
| Property and equipment, gross | 2,622 | - | ||
| Less accumulated depreciation and amortization | 2,430 | - | ||
| Property and equipment, net | 192 | 225 | ||
| Intangible assets, net | 661 | 681 | ||
| Right-of-use assets | 425 | 504 | ||
| Deposits and other assets | 31 | 31 | ||
| Total assets | 5,282 | 5,547 | ||
| Accounts payable | 265 | 397 | ||
| Accrued liabilities | 452 | 651 | ||
| Operating lease liabilities, current | 383 | 371 | ||
| Advances | 250 | 250 | ||
| Related party note payable | 3,305 | 3,270 | ||
| Total current liabilities | 4,655 | 4,939 | ||
| Operating lease liabilities, net of current portion | 103 | 204 | ||
| Total liabilities | 4,758 | 5,143 | ||
| Series d redeemable convertible preferred stock, 0.001 par value 50 shares authorized 43 shares issued and outstanding liquidation preference of 4,300 at september 30, 2025 and december 31, 2024-Series DRedeemable Convertible Preferred Stock | 4,300 | 4,300 | ||
| Non-redeemable convertible preferred stock, 0.001 par value 10,004,310 and 10,004,310 shares authorized 5,254,310 and 5,254,310 shares issued and outstanding liquidation preference of 9,823 and 9,811 at september 30, 2025 and december 31, 2024, respectively-Nonredeemable Convertible Preferred Stock | 5 | 5 | ||
| Common stock, 0.001 par value 120,000,000 shares authorized 8,004,389 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 8 | 8 | ||
| Additional paid-in capital | 106,966 | 106,903 | ||
| Accumulated deficit | -110,755 | -110,812 | ||
| Total stockholders' deficit | -3,776 | -3,896 | ||
| Total liabilities, redeemable convertible preferred stock and stockholders' deficit | 5,282 | 5,547 | ||
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)